- AstraZeneca CEO buys 20,000 shares
- Travis Perkins CEO buys 249, 218 shares
- ASOS director buys £430,135 shares
Pascal Soriot, CEO of pharmaceutical firm AstraZeneca (AZN) has bought 20,000 shares at £102 for a total value of £2.04 million on 15 November.
Soriot’s purchase comes after the pharmaceutical giant delivered earnings ahead of consensus forecasts and raised its outlook on 14 November.
Over the past two months the company’s shares have fallen by around 16% after recording an all-time high at the end of August.
Investors may be concerned about recent investigations and detainment of current and former AstraZeneca employees by the Chinese authorities.
AstraZeneca however is adamant it has not received any notification that it is being investigated as reported previously by Shares.
TRAVIS PERKINS CEO BUYS 249,218 SHARES
Peter Redfern, CEO of FTSE 250 builders’ merchant Travis Perkins (TPK) has bought 249,218 shares at 803p for a total value of £1.99 million on 12 November.
Redfern became CEO of the builders’ merchant in September this year, so this move could be seen as vote of confidence in the company.
The company might need a boost after reporting a 6.8% drop in like-for-like revenues in the third quarter recently with sales at the general merchant arm down 8.2%.
Travis Perkins also said it expects a 25% reduction in annual profits this year reiterating what it said in August.
Over the past year shares have gained 2%.
ASOS DIRECTOR BUYS £430,135 SHARES
A person closely associated with William Barker, Camelot Capital Partners, who is non-executive director of online fast-fashion retailer ASOS (ASC) has bought 125,210 shares at 344p for a total value of £430,135 on 12 November.
Following the transaction Camelot holds 17,738,591 shares.
On 5 November ASOS reported a pre-tax loss of £379.3 million for the year ending 1 September with sales falling by 18% to £2.9 billion.
Year-to-date Asos shares are down 9% to 359p.
